High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Cloud and AI infrastructure names are pushing higher midday Friday against a softer broad tape. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.4% to $769.81, while the Invesco QQQ Trust (NASDAQ:QQQ) is down 0.1% to $717.34. Capital continues to flow into specific corners of the AI buildout. IREN (NASDAQ:IREN) stock is up 4% […]
OBDC's Q2 earnings beat estimates as lower interest expenses help offset weaker interest income and declining net investment income.
Default rates are hitting recent highs, and internal reviews of loan health point to tougher times ahead, a WSJ analysis shows.
(Bloomberg) -- Latigo Biotherapeutics Inc., a clinical-stage developer of non-opioid pain medicines, climbed 17% on Friday after raising $345.6 million in an upsized initial public offering, priced at the top of a marketed range.Most Read from BloombergOpenAI’s New Device Will Be Hockey Puck-Sized and Cost Over $300Iran Wants to Bar US, Israeli Ships From Hormuz in Peace AccordIran Says Agreement on Hormuz Shipping Reached With OmanTrump Administration Considers Order on Autism and VaccinesWhy D
ARX partners with WoodStar to add $220M+ in underwriting capacity, advancing its fee-based model and expanding insurance growth opportunities.
(Bloomberg) -- Blue Owl Capital Inc. is in advanced talks to buy a minority stake of the NBA’s Cleveland Cavaliers, according to people familiar with the matter. Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetGrand Ole Opry House Up For Sale by Owner Ryman HospitalityStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapMicron Soars After AI-Fueled Forecast Shatters EstimatesStocks Climb Late After Micron’s Blowout Outlook: Markets WrapThe transa
In the first quarter of 2026, Blue Owl Capital Inc. reported higher revenue and net income year over year, raised its quarterly dividend to US$0.23 per share, and continued its share repurchase program, buying back 1,710,117 shares for US$24.97 million and completing US$78.58 million of buybacks under its 2025 authorization. The company also partially realized a large gain on its early SpaceX investment and advanced its real assets and data-center platforms, highlighting how diversified...
(Bloomberg) -- Blue Owl Capital is preparing to launch a debut credit secondaries strategy and is in early-stage talks with prospective investors for the fund, according to a person familiar with the matter.Most Read from BloombergUS Has Opened a Passage Through Hormuz, Central Command SaysDOJ Plans Intervention in Trump Supreme Court Carroll AppealBillionaire Duke of Westminster to Sell £700 Million of US Real Estate AssetsChina Asks Banks to Pause New Loans to US-Sanctioned RefinerSony to Pay
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.